Proactive Investors - Run By Investors For Investors

Avacta Group PLC agrees major co-development partnership with US business

Alastair Smith, chief executive of Avacta Group Plc (LON: AVCT), discusses with Proactive's Andrew Scott a co-development partnership that's been agreed with a US business.

Smith says they're teaming up with Bach BioSciences, a company commercialising the research of William Bachovchin, a professor at Tufts University School of Medicine, Boston.

In what is described as a “ground-breaking” co-invention, the two companies have developed a new class of drug conjugate for cancer.

 
Meet Cardinal Resources Ltd and Legend Mining Ltd at our event, Melbourne , 16 July 2019. Register here »
View full AVCT profile View Profile

Avacta Group PLC Timeline

CN Research
April 09 2019

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use